Browsing: cancer

In a significant move to bolster the local biotech industry, global biotech leader Amgen and NSG BioLabs, Singapore’s premier provider of biotech co-working laboratories, have announced VerImmune as the latest winner of their prestigious Golden Ticket Programme. This announcement underscores their commitment to fostering innovation and collaboration in Singapore’s burgeoning biotech sector.

Neuroblastoma is a complex childhood cancer that demands our attention. This article provides a detailed exploration of neuroblastoma, including its origins, symptoms, diagnostic procedures, treatment methods, and prognosis.

Singapore, renowned for its advanced healthcare infrastructure and expertise, stands out as a hub for cancer treatment in Southeast Asia. With a plethora of highly skilled oncologists and state-of-the-art medical facilities, the city-state offers patients access to world-class cancer care. In this detailed exploration, we delve into what makes an oncologist stand out in Singapore, the criteria for selecting the best, and highlight some of the leading specialists and institutions in the field.

In an unprecedented and strategic move, the U.S. Food and Drug Administration (FDA) has granted permission for the temporary import of an unapproved Chinese cancer drug. The decision comes amid a growing shortage of vital cancer drugs in the US, notably cisplatin, a widely used chemotherapy medication. The crisis has prompted the FDA to consider unconventional approaches, and this move stands as testament to that flexibility.

Endocrine-disrupting chemicals (EDCs) are a silent menace that infiltrate our daily lives, impacting our health in subtle yet significant ways. These stealthy substances can interfere with our hormonal balance, leading to a myriad of health issues. In Asia, where rapid industrialisation and urbanisation have intensified the presence of EDCs, understanding their sources, effects, and ways to reduce exposure is crucial. This article delves into the world of endocrine disruptors and their impact on Asia’s health landscape.

CytoMed Therapeutics has developed a revolutionary new cancer treatment that uses modified white blood cells from healthy donors to recognize and destroy cancer cells. The therapy is being trialled in Singapore on patients with the most common types of cancer. If successful, the treatment could lead to more efficient and accessible CAR-T cell therapies for a range of solid and blood cancers.